Septerna, Inc. $SEPN Shares Bought by First Light Asset Management LLC

First Light Asset Management LLC raised its holdings in Septerna, Inc. (NASDAQ:SEPN) by 18.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 732,860 shares of the company’s stock after acquiring an additional 112,049 shares during the period. Septerna accounts for 1.6% of First Light Asset Management LLC’s holdings, making the stock its 21st biggest holding. First Light Asset Management LLC’s holdings in Septerna were worth $17,611,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Group One Trading LLC boosted its stake in shares of Septerna by 111.8% in the fourth quarter. Group One Trading LLC now owns 944 shares of the company’s stock worth $26,000 after buying an additional 8,955 shares during the last quarter. Global Retirement Partners LLC acquired a new position in Septerna in the fourth quarter valued at approximately $35,000. Russell Investments Group Ltd. purchased a new stake in Septerna in the 3rd quarter worth approximately $36,000. Caitong International Asset Management Co. Ltd purchased a new stake in Septerna in the 4th quarter worth approximately $53,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Septerna during the 4th quarter worth approximately $61,000.

Insiders Place Their Bets

In other news, SVP Daniel D. Long sold 15,000 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $35.51, for a total transaction of $532,650.00. Following the completion of the sale, the senior vice president owned 96,412 shares of the company’s stock, valued at $3,423,590.12. The trade was a 13.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Samira Shaikhly sold 11,798 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $30.06, for a total transaction of $354,647.88. Following the sale, the insider directly owned 793 shares of the company’s stock, valued at $23,837.58. This represents a 93.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 44,494 shares of company stock valued at $1,469,391 over the last 90 days. 5.80% of the stock is currently owned by company insiders.

Septerna Price Performance

Shares of SEPN stock opened at $33.10 on Monday. Septerna, Inc. has a 1-year low of $10.62 and a 1-year high of $38.04. The company has a market cap of $1.49 billion, a price-to-earnings ratio of -40.86 and a beta of 2.29. The stock has a 50 day simple moving average of $32.91 and a 200-day simple moving average of $28.30.

Septerna (NASDAQ:SEPN) last released its quarterly earnings results on Monday, May 11th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.23. Septerna had a negative net margin of 49.88% and a negative return on equity of 12.72%. The firm had revenue of $26.52 million for the quarter, compared to analysts’ expectations of $16.98 million. Analysts anticipate that Septerna, Inc. will post -1.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on SEPN shares. HC Wainwright reaffirmed a “buy” rating and set a $40.00 target price on shares of Septerna in a report on Wednesday, July 1st. Raymond James Financial raised their price target on shares of Septerna from $47.00 to $53.00 and gave the company a “strong-buy” rating in a research report on Monday, June 8th. Truist Financial lifted their price objective on shares of Septerna from $35.00 to $43.00 and gave the company a “buy” rating in a report on Wednesday, July 1st. Guggenheim lowered their target price on shares of Septerna from $52.00 to $45.00 and set a “buy” rating on the stock in a research note on Wednesday, July 1st. Finally, Stifel Nicolaus initiated coverage on Septerna in a research report on Friday, May 1st. They set a “buy” rating and a $43.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Septerna currently has a consensus rating of “Moderate Buy” and a consensus price target of $45.89.

Septerna Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. GPCRs are the largest and most diverse family of cell membrane receptors and regulate physiological processes in nearly every organ system of the human body.